Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Submitted by
admin
on March 8, 2016 - 10:14am
Source:
Bidness, ETC
News Tags:
Novo Nordisk
Eli Lilly
Merck
diabetes
Victoza
Headline:
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Do Not Allow Advertisers to Use My Personal information
